Clinical trial
AMPLATZER™ Amulet™ LAA Occluder Trial
NCT02879448 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT02879448 |
|---|---|
| Title | AMPLATZER™ Amulet™ LAA Occluder Trial |
| Official title | AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial |
| Acronym | Amulet IDE |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Stroke |
| Intervention type | Device |
| Interventions | Amulet Left Atrial Appendage Occluder, WATCHMAN Left Atrial Appendage Closure |
| Enrollment | 1,878 |
| Start date | Aug 24, 2016 |
| Primary completion | Dec 7, 2020 |
| Completion | May 24, 2024 |
| First posted | Aug 25, 2016 |
| Last update posted | Feb 26, 2025 |
| Countries | Australia, Canada, Czechia, Denmark, Germany, Italy, Netherlands, Portugal, Spain, Switzerland, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: